Waverly Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Waverly Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$501K	Sell	2,495 -35	-1%	-$7.24K	﹤0.01%	1084
2025 Q4	$523K	Buy	+2,530	New	+$506K	﹤0.01%	989
2024 Q4	–	Sell	-7,941	Closed	-$1.37M	–	996
2024 Q3	$1.37M	Sell	7,941 -48	-0.6%	-$7.95K	0.03%	395
2024 Q2	$1.23M	Buy	7,989 +72	+0.9%	+$10.8K	0.02%	403
2024 Q1	$1.22M	Buy	7,917 +100	+1%	+$15.2K	0.03%	334
2023 Q4	$1.24M	Hold	7,817	–	–	0.05%	196
2023 Q3	$1.14M	Hold	7,817	–	–	0.05%	184
2023 Q2	$1.2M	Hold	7,817	–	–	0.05%	169
2023 Q1	$1.21M	Hold	7,817	–	–	0.06%	131
2022 Q4	$1.2M	Hold	7,817	–	–	0.07%	121
2022 Q3	$1.03M	Hold	7,817	–	–	0.07%	106
2022 Q2	$1.06M	Hold	7,817	–	–	0.1%	80
2022 Q1	$1.17M	Hold	7,817	–	–	0.1%	73
2021 Q4	$1.17M	Buy	7,817 +4,238	+118%	+$685K	0.1%	70
2021 Q3	$573K	Buy	+3,579	New	+$611K	0.05%	115
2015 Q1	–	Sell	-159	Closed	-$16K	–	369
2014 Q4	$16K	Hold	159	–	–	0.01%	236
2014 Q3	$15K	Buy	159 +69	+77%	+$5.99K	0.01%	394
2014 Q2	$7K	Buy	+90	New	+$6.88K	﹤0.01%	520

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Waverly Advisors's FBT Position: Q1 2026 in Review

Waverly Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1.4% in Q1 2026, selling an estimated $7.24K and leaving 2,495 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #1084.

Waverly Advisors first reported a position in FBT in Q2 2014 and has held it in 18 quarters since. The position peaked at $1.37M in Q3 2024. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Waverly Advisors held 2,495 shares of First Trust NYSE Arca Biotechnology Index Fund worth $501K as of Q1 2026.
Waverly Advisors sold 35 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $7.24K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Waverly Advisors's portfolio in Q1 2026, its #1084 holding.
Waverly Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2014 and has held it in 18 quarters since.
Waverly Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.37M in Q3 2024.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.